PRCT
Price
$20.03
Change
+$1.76 (+9.63%)
Updated
Oct 22 closing price
Capitalization
1.15B
13 days until earnings call
Intraday BUY SELL Signals
RDNT
Price
$70.26
Change
+$1.85 (+2.70%)
Updated
Oct 22 closing price
Capitalization
5.53B
18 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PRCT vs RDNT

PRCT vs RDNT Comparison Chart in %
View a ticker or compare two or three
VS
PRCT vs. RDNT commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRCT is a Hold and RDNT is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for PRCT with price predictions
Oct 22, 2026

PRCT's RSI Oscillator ascends from oversold territory

The RSI Indicator for PRCT moved out of oversold territory on September 29, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 37 similar instances when the indicator left oversold territory. In 33 of the 37 cases the stock moved higher. This puts the odds of a move higher at 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 51 of 65 cases where PRCT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.

The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on PRCT as a result. In 74 of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.

The Moving Average Convergence Divergence (MACD) for PRCT just turned positive on October 08, 2026. Looking at past instances where PRCT's MACD turned positive, the stock continued to rise in 28 of 46 cases over the following month. The odds of a continued upward trend are 61%.

PRCT moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +7.11% 3-day Advance, the price is estimated to grow further. Considering data from situations where PRCT advanced for three days, in 193 of 264 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.

Bearish Trend Analysis

The 10-day moving average for PRCT crossed bearishly below the 50-day moving average on September 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 80%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRCT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

PRCT broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for PRCT entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 21 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.373) is normal, around the industry mean (2.874). P/E Ratio (-10.272) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (3.249) is also within normal values, averaging (40.124).

The Tickeron PE Growth Rating for this company is 46 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. PRCT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PRCT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

A.I.Advisor
a Summary for RDNT with price predictions
Oct 22, 2026

Momentum Indicator for RDNT turns positive, indicating new upward trend

RDNT saw its Momentum Indicator move above the 0 level on October 22, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 86 similar instances where the indicator turned positive. In 70 of the 86 cases, the stock moved higher in the following days. The odds of a move higher are at 81%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for RDNT just turned positive on October 22, 2026. Looking at past instances where RDNT's MACD turned positive, the stock continued to rise in 42 of 55 cases over the following month. The odds of a continued upward trend are 76%.

Following a +1.23% 3-day Advance, the price is estimated to grow further. Considering data from situations where RDNT advanced for three days, in 233 of 315 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 44 of 59 cases where RDNT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 75%.

RDNT moved below its 50-day moving average on September 29, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for RDNT crossed bearishly below the 50-day moving average on October 01, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 80%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RDNT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.

The Aroon Indicator for RDNT entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.045) is normal, around the industry mean (66.046). RDNT's P/E Ratio (-270.231) is considerably lower than the industry average of (2.422). Projected Growth (PEG Ratio) (0.260) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (2.567) is also within normal values, averaging (9.775).

The Tickeron Profit vs. Risk Rating rating for this company is 45 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating fairly steady price growth. RDNT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 60 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
RDNT: Fundamental Ratings
RDNT
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
PROFIT vs RISK RATING
1..100
45
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
60
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PRCTRDNT
RSI
ODDS (%)
Bullish Trend 1 day ago
89%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
75%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
75%
Advances
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
74%
Declines
ODDS (%)
Bearish Trend 9 days ago
82%
Bearish Trend 15 days ago
74%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (PRCT: $18.27 vs. RDNT: $68.41)
Brand notoriety: PRCT and RDNT are both not notable
PRCT represents the Medical/Nursing Services, while RDNT is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: PRCT: 58% vs. RDNT: 72%
Market capitalization -- PRCT: $1.15B vs. RDNT: $5.53B
PRCT [@Medical/Nursing Services] is valued at $1.15B. RDNT’s [@Medical Specialties] market capitalization is $5.53B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $173.92B. The market cap for tickers in the [@Medical Specialties] industry ranges from $27 to $4.39T. The average market capitalization across the [@Medical/Nursing Services] industry is $5.76B. The average market capitalization across the [@Medical Specialties] industry is $20.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRCT’s FA Score shows that 2 FA rating(s) are green while RDNT’s FA Score has 1 green FA rating(s).

  • PRCT’s FA Score: 2 green, 3 red.
  • RDNT’s FA Score: 1 green, 4 red.
According to our system of comparison, RDNT is a better buy in the long-term than PRCT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRCT’s TA Score shows that 5 TA indicator(s) are bullish while RDNT’s TA Score has 1 bullish TA indicator(s).

  • PRCT’s TA Score: 5 bullish, 4 bearish.
  • RDNT’s TA Score: 1 bullish, 7 bearish.
According to our system of comparison, PRCT is a better buy in the short-term than RDNT.

Price Growth

PRCT (@Medical/Nursing Services) experienced а +4.34% price change this week, while RDNT (@Medical Specialties) price change was -1.08% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.62%. For the same industry, the average monthly price growth was -10.72%, and the average quarterly price growth was -10.29%.

The average weekly price growth across all stocks in the @Medical Specialties industry was -3.15%. For the same industry, the average monthly price growth was -6.50%, and the average quarterly price growth was +42.74%.

Reported Earning Dates

PRCT is expected to report earnings on Nov 04, 2026.

RDNT is expected to report earnings on Nov 09, 2026.

Industries' Descriptions

@Medical/Nursing Services (-1.62% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Medical Specialties (-3.15% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

View a ticker or compare two or three
PRCT
Daily Signal:
Gain/Loss:
RDNT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

PRCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRCT has been loosely correlated with TWST. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if PRCT jumps, then TWST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRCT
1D Price
Change %
PRCT100%
+9.63%
TWST - PRCT
37%
Loosely correlated
-9.16%
RDNT - PRCT
35%
Loosely correlated
+2.70%
NTRA - PRCT
35%
Loosely correlated
-2.91%
DCTH - PRCT
34%
Loosely correlated
+0.34%
GH - PRCT
33%
Poorly correlated
-2.23%
More

RDNT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RDNT has been loosely correlated with ITGR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if RDNT jumps, then ITGR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RDNT
1D Price
Change %
RDNT100%
+2.70%
ITGR - RDNT
49%
Loosely correlated
-0.11%
GKOS - RDNT
48%
Loosely correlated
-0.09%
NNOX - RDNT
46%
Loosely correlated
-0.36%
ICUI - RDNT
43%
Loosely correlated
+4.66%
CERS - RDNT
42%
Loosely correlated
-3.35%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GMOD27.740.02
+0.09%
GMO Dynamic Allocation ETF (GMOD)
IEUS69.73-0.82
-1.16%
iShares MSCI Europe Small-Cap ETF (IEUS)
HCMT40.15-1.73
-4.14%
Direxion HCM Tactical Enhanced US ETF (HCMT)
BETE38.12-1.65
-4.14%
ProShares Bitcoin & Ether Equal Weight ETF (BETE)
FLTW99.88-4.85
-4.63%
Franklin FTSE Taiwan ETF (FLTW)